Recent Texas appellate decisions reflect an increased scrutiny of large awards for noneconomic damages. Together, Gregory v. Chohan, Exxon Mobil Corp. v. Brown, and Jones v. Hatch reflect an emerging trend: noneconomic damages must be grounded in the evidentiary record
In the insurance industry, insurers often maintain split files for complex liability claims as an administrative control that enables their defense of an insured(s) while simultaneously investigating coverage issues. While some insurers maintain split files for all claims, others may
When luxury or collector vehicles are placed on consignment for sale, the lines of responsibility can become blurred if a loss occurs. This blurred line was illustrated in a recent claim involving two Porsche 911 GTS GT3 RSs valued at
OSHA does not have a specific rule that addresses workplace violence in general industry or health care, although it has long discussed the need for such rules. During the Biden Administration some progress was made to advance a workplace violence
In Deja Realty Corp. v. Travelers Indemnity Company of America, 2026 WL 683303 (S.D.N.Y. 2026), the United States District Court for the Southern District of New York granted summary judgment to the insurer, holding that the insured’s year-long delay in
In this episode of Subro on the Go, regular co-hosts, David Brisco (San Diego) and Joe Rich (Miami) are joined by Joseph Duque (San Diego) to commence our Back to Basic series. In 2026 we are covering the key steps
Oregon House Bill 3746, which became law on July 24, 2025 and became effective on January 1, 2026, operates to shorten the statute of repose for “a tort action by a homeowners association or association of unit owners arising from
As part of Florida’s March 2023 tort and insurance reforms, the Florida legislature introduced a safe harbor for carriers to avoid bad faith liability in claims involving multiple third party claimants. The provision appears in Fla. Stat. 624.155(6) and states
As part of OSHA’s efforts to enhance compliance assistance, it launched its “Safety Champions Program” (SCP) effective February 24, 2026. SCP is a new program for employers to develop and implement an effective safety and health program. The SCP incorporates
On February 23, the FDA announced a new approval pathway designed to support the development of drugs for ultra-rare diseases. Often, treatments for ultra-rare diseases have difficulty meeting the agency’s rigorous approval requirements. The FDA has issued a guidance document
